NAGE niagenbioscience.com: Expected earnings per share growth for next year
Chromadex Corp is optimizing costs by outsourcing component synthesis to certified external laboratories. The company strictly adheres to ESG standards by reducing plastic use and conserving water resources. Stable revenue is driven by B2B supplies of Niagen to the pharmaceutical industry. A promising assessment of net profit dynamics demonstrates market consensus, with the indicator level standing at -29.00.
Analytical breakdowns for Chromadex Corp
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
Debt to Equity Chromadex Corp|NAGE - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital niagenbioscience.com|NAGE - Company Cumulative Debt|Debt to Book Capitalization Ratio ChromaDex Corporation|NAGE - Company Long-Term Indebtedness|Company Current Liabilities ChromaDex|Quick Liquidity niagenbioscience.com
- net income and valuation ratios data:
NAGE - Net Financial Result|Projected Future Earnings Chromadex Corp|NAGE - Price to Earnings Ratio|Forward P/E Multiple Chromadex Corp|NAGE - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Niagen|NAGE - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months ChromaDex|NAGE - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months niagenbioscience.com|NAGE - Net earnings per share growth this year|Earnings growth forecast for next year Chromadex Corp
- sales and revenue indicators:
Fundamental company analysis:NAGE, ChromaDex
This indicator measures the expected growth rate of earnings per share, reflecting the business's ability to capitalize future cash flows under current interest rates. For Chromadex Corp (NAGE), this benchmark for the company's EPS dynamics for the coming year demonstrates a balance between stable subscription revenue from Tru Niagen and FDA regulatory constraints that are limiting the expansion pace of the ecosystem.
Competing companies
Net earnings per share growth forecast for next year intuitive.com|DHR (danaher.com) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Becton Dickinson (BDX)|STE (STERIS Corporation) - Expected earnings per share trend next year|West Pharma - Expected earnings per share growth for next year|Earnings growth forecast for next year Baxter Healthcare BAX|MASI: Expected earnings per share growth for next year|STVN - Earnings growth forecast for next year|TFX: Earnings growth forecast for next year|Expected earnings per share growth for next year Merit Medical|NVST (envistaco.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year ICU Medical Inc. ICUI|Net earnings per share growth forecast for next year Dentsply Sirona (XRAY)|LeMaitre Vascular - Projected earnings per share growth rate for next year|AtriCure, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year STAA (STAAR Surgical Co.)|ZIMV - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year AngioDynamics Corp ANGO|CERS: Earnings growth forecast for next year|teknova.com (TKNO) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Monogram Orthopedics Inc.|STSS: Expected earnings per share trend next year|Earnings growth forecast for next year INFU|Earnings growth forecast for next year Utah Medical (UTMD)|KORU Medical Systems, Inc. - Expected earnings per share growth for next year|Nyxoah S.A. (NYXH) - Expected net earnings per share growth next year|MBOT - Net earnings per share growth forecast for next year|PDEX (Pro-Dex) - Projected earnings per share growth rate for next year|Zentek Ltd (ZTEK) - Net earnings per share growth forecast for next year|Elutia Inc. (ELUT) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Milestone Scientific Inc|NXGL: Expected earnings per share trend next year|Earnings growth forecast for next year RVP|HBIO (Harvard Bioscience, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year FEMY (Femasys Corporation)|MHUA: Projected earnings per share growth rate for next year|Predictive Oncology Corp - Earnings growth forecast for next year|CJMB: Net earnings per share growth forecast for next year|Atrion Corporation (ATRI) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year NURO
